” She reported which the scientific trials were limited to wholesome women, but that if approved the drug could well be used by a wider range of women, resulting in “an epidemic of adverse occasions.”Research suggests that Addyi and Vyleesi provide smaller benefits to premenopausal women with sexual arousal disorders.Skene’s glands consist